BRIEF-Natco Pharma Gets Emergency Use Nod For Baricitinib Tablets For COVID-19 Treatment

  • Reuters
BRIEF-Natco Pharma Gets Emergency Use Nod For Baricitinib Tablets For COVID-19 Treatment

May 3 (Reuters) - Natco Pharma Ltd NATP.NS :

* NATCO RECEIVES EMERGENCY USE APPROVAL FOR BARICITINIB TABLETS FOR COVID-19 TREATMENT

* NATCO WILL BE REQUESTING A COMPULSORY LICENSE BASED ON EMERGENCY USE

* COMPANY IS READY TO LAUNCH THE PRODUCT THIS WEEK

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles